Emcor
EME NYSE Construction & Engineering Financials FY2016βFY2025
Emcor's revenue rose 16.6% to $17.0 billion in fiscal 2025. Its operating margin was 10.1%, up from 9.2% a year earlier. Free cash flow was $1.2 billion, down 10.8%. It paid out $631 million in dividends and buybacks, 53% of free cash flow. The diluted share count fell 3.5%.
About these figures. EMCOR repaid its term loan in 2023 and its 10-K reports no borrowings under its credit facility at the end of 2024 and 2025, so its debt counts as zero from 2024 (earlier figures include its finance leases).
What Emcor does
No business description yet.
- Legal name
- EMCOR Group, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000105634-26-000025
0000105634
Revenue and margins
Emcor had $17.0B of revenue in fiscal 2025, up 16.6% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 28.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.2B in fiscal 2025, 7.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Emcor returned $631M to shareholders in fiscal 2025, 53% of free cash flow. The diluted share count fell 3.6%.
Value Emcor yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $1.1B and divides by 45.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 20.2x Β· peers 27.7x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Emcor can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $821M | $456M | $790M | $1.3B | $1.1B |
| Debt incl. finance leases | $262M | $247M | $5.3M | $6.1M | $6.3M |
| Net debt / EBITDA | β1.0x | β0.3x | β0.9x | β0.9x | β0.6x |
| Debt / equity | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 87.4x | 42.8x | 50.9x | 355.9x | 142.6x |
| Current ratio | 1.4x | 1.3x | 1.3x | 1.3x | 1.2x |
| Quick ratio | 1.4x | 1.3x | 1.3x | 1.3x | 1.2x |
| Total assets | $5.4B | $5.5B | $6.6B | $7.7B | $9.3B |
| Total liabilities | $3.2B | $3.6B | $4.1B | $4.8B | $5.6B |
| Shareholders' equity | $2.3B | $2.0B | $2.5B | $2.9B | $3.7B |
| Net debt (β = net cash) | β$560M | β$209M | β$785M | β$1.3B | β$1.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
1 insider
Sold, 12 months
$40.8M
9 insiders
Of sales under plans
64%
$26.3M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | McEvoy M KevinDirector | Bought | 2 | $736.79 | $0.0M | Form 4 |
| Jun 17, 2026 | Carol P LoweDirector | Sold | 950 | $844.50 | $0.8M | Form 4 |
| Jun 17, 2026 | McEvoy M KevinDirector | Bought | 1 | $826.31 | $0.0M | Form 4 |
| May 11, 2026 | William P ReidDirector | Sold | 2,000 | $925.78 | $1.9M | Form 4 |
| May 1, 2026 | John W AltmeyerDirector | Sold | 2,500 | $895.00 | $2.2M | Form 4 |
| Apr 30, 2026 | Jason R NalbandianSVP, CFO, Chief Acct. Officer | Sold | 800 | $856.43 | $0.7M | Form 4 |
| Apr 30, 2026 | Robert Peter LindVP and Controller | Sold | 675 | $894.27 | $0.6M | Form 4 |
| Apr 30, 2026 | Steven SchwarzwaelderDirector | Sold | 5,602 | $895.19 | $5.0M | Form 4 |
| Mar 5, 2026 | Anthony GuzziChairman, President and CEO, Director | Sold plan | 36,000 | $729.48 | $26.3M | Form 4 |
| Mar 2, 2026 | Maxine Lum MauricioCAO, EVP & General Counsel | Sold | 3,357 | $735.00 | $2.5M | Form 4 |
| Dec 23, 2025 | Robert Peter LindVP and Controller | Sold | 0 | $625.09 | $0.0M | Form 4 |
| Nov 3, 2025 | Robin A Walker-LeeDirector | Sold | 1,325 | $677.22 | $0.9M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 9 / 9 | 8 / 9 | 6 / 9 |
| Accruals ratio | β4.4% | β5.6% | β0.3% |
| Altman Z'' | 4.32 | 4.89 | 4.79 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Emcor EME | $28.9B | 16.6% | 10.1% | 7.0% | 60.7% | 20.2x | 6 | |
| AECOM ACM | $7.8B | 0.2% | 6.4% | 4.2% | 22.4% | 27.7x | 7 | Compare β |
| Fluor FLR | $6.2B | β5.0% | β2.4% | β2.8% | β13.9% | β | 3 | Compare β |
| MasTec MTZ | $13.5B | 16.2% | β | 2.0% | 11.2% | 27.3x | 7 | Compare β |
| Jacobs Solutions J | $17.2B | 4.6% | 7.2% | 5.1% | 10.1% | 50.9x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $7.6B | $7.7B | $8.1B | $9.2B | $8.8B | $9.9B | $11.1B | $12.6B | $14.6B | $17.0B |
| Gross profit | $1.0B | $1.1B | $1.2B | $1.4B | $1.4B | $1.5B | $1.6B | $2.1B | $2.8B | $3.3B |
| Operating income | $307M | $329M | $403M | $461M | $257M | $531M | $565M | $876M | $1.3B | $1.7B |
| Interest expense | $12.6M | $12.8M | $13.5M | $13.8M | $9.0M | $6.1M | $13.2M | $17.2M | $3.8M | $12.0M |
| Pretax income | $297M | $319M | $395M | $451M | $252M | $529M | $559M | $873M | $1.4B | $1.7B |
| Income tax | $111M | $90.7M | $109M | $126M | $119M | $146M | $153M | $240M | $370M | $449M |
| Net income | $182M | $227M | $284M | $325M | $133M | $384M | $406M | $633M | $1.0B | $1.3B |
| Diluted EPS | $2.97 | $3.82 | $4.85 | $5.75 | $2.40 | $7.06 | $8.10 | $13.31 | $21.52 | $28.19 |
| Diluted shares | 0.06B | 0.06B | 0.06B | 0.06B | 0.06B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $262M | $366M | $271M | $356M | $806M | $319M | $498M | $900M | $1.4B | $1.3B |
| Capital expenditure | $39.6M | $34.7M | $43.5M | $48.4M | $48.0M | $36.2M | $49.3M | $78.4M | $75.0M | $113M |
| Free cash flow | $223M | $331M | $228M | $307M | $758M | $283M | $449M | $821M | $1.3B | $1.2B |
| Depreciation and amortization | $38.9M | $39.9M | $38.5M | $43.9M | $46.7M | $48.3M | $47.3M | $51.8M | $134M | $186M |
| Acquisitions | $233M | $107M | $72.1M | $301M | $50.4M | $118M | $98.7M | $96.5M | $228M | $1.0B |
| Share buybacks | $94.2M | $93.2M | $216M | $0.0M | $113M | $196M | $661M | $128M | $490M | $586M |
| Dividends paid | $19.5M | $19.0M | $18.6M | $17.9M | $17.7M | $28.2M | $27.2M | $32.7M | $43.4M | $45.0M |
| Dividends and buybacks | $114M | $112M | $235M | $18.0M | $130M | $224M | $688M | $160M | $533M | $631M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $465M | $467M | $364M | $359M | $903M | $821M | $456M | $790M | $1.3B | $1.1B |
| Total debt | $408M | $310M | $296M | $294M | $277M | $262M | $247M | $5.3M | $0.0M | $0.0M |
| Finance lease liabilities | $0.0M | $0.0M | $4.2M | $9.7M | $10.0M | $8.0M | $6.5M | $5.3M | $6.1M | $6.3M |
| Current assets | $2.2B | $2.3B | $2.4B | $2.7B | $3.1B | $3.4B | $3.5B | $4.4B | $5.4B | $5.9B |
| Current liabilities | $1.5B | $1.7B | $1.7B | $1.9B | $2.2B | $2.4B | $2.8B | $3.5B | $4.2B | $4.9B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $128M | $127M | $134M | $156M | $158M | $152M | $158M | $179M | $208M | $253M |
| Total assets | $3.9B | $4.0B | $4.1B | $4.8B | $5.1B | $5.4B | $5.5B | $6.6B | $7.7B | $9.3B |
| Total liabilities | $2.3B | $2.3B | $2.3B | $2.8B | $3.0B | $3.2B | $3.6B | $4.1B | $4.8B | $5.6B |
| Shareholders' equity | $1.5B | $1.7B | $1.7B | $2.1B | $2.1B | $2.3B | $2.0B | $2.5B | $2.9B | $3.7B |
| Margins | ||||||||||
| Gross margin | 13.7% | 14.9% | 14.8% | 14.8% | 15.9% | 15.2% | 14.5% | 16.6% | 19.0% | 19.3% |
| Operating margin | 4.1% | 4.3% | 5.0% | 5.0% | 2.9% | 5.4% | 5.1% | 7.0% | 9.2% | 10.1% |
| EBITDA margin | 4.6% | 4.8% | 5.4% | 5.5% | 3.5% | 5.9% | 5.5% | 7.4% | 10.2% | 11.2% |
| Net margin | 2.4% | 3.0% | 3.5% | 3.5% | 1.5% | 3.9% | 3.7% | 5.0% | 6.9% | 7.5% |
| FCF margin | 3.0% | 4.3% | 2.8% | 3.4% | 8.6% | 2.9% | 4.1% | 6.5% | 9.2% | 7.0% |
| Returns | ||||||||||
| Return on capital | 13.8% | 15.7% | 18.3% | 18.1% | 7.9% | 24.7% | 23.7% | 36.8% | 59.8% | 60.7% |
| Return on capital employed | 13.8% | 14.1% | 17.3% | 17.6% | 8.9% | 17.8% | 19.3% | 29.9% | 40.4% | 42.9% |
| Return on equity | 12.1% | 14.2% | 16.6% | 17.1% | 6.5% | 17.8% | 19.2% | 28.5% | 37.3% | 38.5% |
| Return on assets | 4.9% | 5.8% | 7.0% | 7.3% | 2.7% | 7.3% | 7.4% | 10.4% | 14.1% | 15.0% |
| Growth | ||||||||||
| Revenue growth | 12.4% | 1.8% | 5.8% | 12.8% | β4.1% | 12.6% | 11.8% | 13.6% | 15.8% | 16.6% |
| Net income growth | 5.6% | 24.9% | 24.8% | 14.7% | β59.1% | 188.5% | 5.9% | 55.9% | 59.1% | 26.4% |
| EPS growth | 9.2% | 28.6% | 27.0% | 18.6% | β58.3% | 194.2% | 14.7% | 64.3% | 61.7% | 31.0% |
| FCF growth | β3.7% | 48.8% | β31.3% | 35.0% | 146.8% | β62.7% | 58.7% | 83.1% | 62.3% | β10.8% |
| Share count change | β3.3% | β2.6% | β2.0% | β3.3% | β1.9% | β1.9% | β7.8% | β5.1% | β1.6% | β3.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.2x | β0.4x | β0.2x | β0.1x | β2.1x | β1.0x | β0.3x | β0.9x | β0.9x | β0.6x |
| Debt / equity | 0.3x | 0.2x | 0.2x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 24.3x | 25.8x | 29.8x | 33.4x | 28.5x | 87.4x | 42.8x | 50.9x | 355.9x | 142.6x |
| Current ratio | 1.4x | 1.4x | 1.4x | 1.4x | 1.4x | 1.4x | 1.3x | 1.3x | 1.3x | 1.2x |
| Quick ratio | 1.4x | 1.4x | 1.4x | 1.4x | 1.4x | 1.4x | 1.3x | 1.3x | 1.3x | 1.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.5% | 0.5% | 0.5% | 0.5% | 0.6% | 0.4% | 0.5% | 0.6% | 0.5% | 0.7% |
| Payouts / FCF | 51.0% | 33.8% | 103.2% | 5.8% | 17.2% | 79.2% | 153.3% | 19.5% | 40.0% | 53.1% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 7.0 | 6.0 | 7.0 | 7.0 | 6.0 | 6.0 | 9.0 | 8.0 | 6.0 |
| Altman Z'' | 3.7 | 3.9 | 4.1 | 4.0 | 3.9 | 4.3 | 4.0 | 4.3 | 4.9 | 4.8 |
| Accruals ratio | β2.2% | β3.6% | 0.3% | β0.7% | β13.6% | 1.2% | β1.7% | β4.4% | β5.6% | β0.3% |
Source: SEC EDGAR XBRL filings (CIK 0000105634). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.